RSV Injection for Infants: Protecting Babies from Serious Illness

A new injection is available to protect infants from severe illness caused by respiratory syncytial virus (RSV). This preventative measure, offered from autumn 2025, is designed for babies born on or after April 1, 2025, and represents a significant step forward in pediatric infectious disease prevention.

Understanding RSV

RSV is a common virus that causes respiratory infections. While it typically presents as a mild cold in many children, it can lead to serious complications, particularly in infants. These complications can include bronchiolitis (inflammation of the small airways in the lungs) and pneumonia, sometimes requiring hospitalization RIVM.

The RSV Injection: How it Works

The injection administered to infants is not a traditional vaccine, but rather an immunization. This means it provides immediate antibodies against the virus, rather than prompting the baby’s immune system to produce them. A single injection offers protection against RSV for approximately six months rijksvaccinatieprogramma.nl.

RSV Protection for Pregnant Women

There is also an RSV vaccination available for pregnant women. This vaccination works by enabling the mother to produce antibodies that are then passed on to the baby via the placenta, providing approximately six months of protection rijksvaccinatieprogramma.nl.

Adjusted Vaccination Timing in the Caribbean

Recent research conducted by Radboud University Medical Center in collaboration with Caribbean hospitals and laboratories suggests that the timing of the RSV injection may necessitate to be adjusted for babies in the Caribbean islands. Unlike the Netherlands, where RSV cases peak in autumn and winter, the virus is most prevalent in the Caribbean during the rainy season, from June to December. Vaccinating babies in the fall may result in diminished antibody levels when the virus resurges in June. The RIVM, responsible for prevention guidelines in Curaçao, Aruba, and Sint Maarten, is currently evaluating whether to adjust the vaccination schedule accordingly.

Impact of the RSV Injection in the Netherlands

Since its introduction last autumn, the RSV injection has demonstrably reduced the number of infants admitted to intensive care units in the Netherlands. The RIVM concluded last month that the decline in severe RSV cases can be largely attributed to the widespread use of the new injection.

Key Takeaways

• A new injection protects infants from severe RSV illness.
• The injection is recommended for babies born on or after April 1, 2025.
• The injection provides six months of protection.
• Pregnant women can also receive an RSV vaccination to protect their babies.
• Vaccination timing may be adjusted in the Caribbean to align with the region’s RSV season.